UMMS Affiliation

Department of Biochemistry and Molecular Pharmacology

Date

8-22-2003

Document Type

Article

Subjects

Base Sequence; Blotting, Northern; Blotting, Western; Cell Line; Cytomegalovirus; Enhancer Elements (Genetics); Gene Expression Regulation, Enzymologic; Green Fluorescent Proteins; Humans; Luminescent Proteins; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; Promoter Regions (Genetics); RNA Interference; RNA, Messenger; RNA, Small Interfering; RNA, Small Nuclear; Superoxide Dismutase; Transfection

Disciplines

Life Sciences | Medicine and Health Sciences

Abstract

Short hairpin RNAs (shRNAs) transcribed by RNA polymerase III (Pol III) promoters can trigger sequence-selective gene silencing in culture and in vivo and, therefore, may be developed to treat diseases caused by dominant, gain-of-function type of gene mutations. These diseases develop in people bearing one mutant and one wild-type gene allele. While the mutant is toxic, the wild-type performs important functions. Thus, the ideal therapy must selectively silence the mutant but maintain the wild-type expression. To achieve this goal, we designed an shRNA that selectively silenced a mutant Cu,Zn superoxide dismutase (SOD1(G93A)) allele that causes amyotrophic lateral sclerosis. However, the efficacy of this shRNA was relatively modest. Since the allele-specific shRNA has to target the mutation site, we could not scan other regions of SOD1 mRNA to find the best silencer. To overcome this problem, we sought to increase the dose of this shRNA by enhancing the Pol III promoter. Here we demonstrate that the enhancer from the cytomegalovirus immediate-early promoter can enhance the U6 promoter activity, the synthesis of shRNA and the efficacy of RNA interference (RNAi). Thus, this enhanced U6 promoter is useful where limited choices of shRNA sequences preclude the selection of a highly efficient RNAi target region.

Rights and Permissions

Citation: Nucleic Acids Res. 2003 Sep 1;31(17):e100.

Related Resources

Link to Article in PubMed

Journal Title

Nucleic acids research

PubMed ID

12930974

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.